People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Other, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RBC Acquisition Corp. | — | Other | Seed | $2.0M | $37.2M | 2013 |
| Pagari Life Science Corp. | — | Pharmaceuticals | Pre-Seed | $525K | $1.5M | 2023 |
David Feldker at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Feldker on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kyle Largent | 1 | 4 |
| John Sateri | 1 | 2 |
| Stephen Peipert | 1 | 1 |
| Alan Wickenhauser | 1 | 1 |
| Stephen Piepert | 1 | 1 |
| James Wickenhauser | 1 | 1 |
| Marni Zenkewicz | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.